Oral Iron Supplementation on Alternate Vs. Consecutive Days for Iron Deficiency Anemia in Pregnancy
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
This will be a randomized clinical trial. Enrolled subjects will be randomized (1:1) into two study arms to receive either daily (Group 1) or alternate day (Group 2) supplementation with one oral pill containing ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: f
View:
• Pregnant patients will be enrolled at less than 30 weeks gestational age (GA) with laboratory confirmed IDA (as defined by hemoglobin under 10.5 g/dL, as well as ferritin under 15 mcg/L)
Locations
United States
Illinois
Southern Illinois University School of Medicine
RECRUITING
Springfield
Contact Information
Primary
Kathleen A Groesch, MS
kgroesch@siumed.edu
217-545-6671
Backup
Teresa S Wilson, BA
twilson2@siumed.edu
217-545-6711
Time Frame
Start Date: 2024-12
Estimated Completion Date: 2028-06-30
Participants
Target number of participants: 120
Treatments
Experimental: 1) Daily dose of ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill
daily (Group 1) supplementation with one oral pill containing ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill
Experimental: 2) Alternate daily dose of ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill
alternate day (Group 2) supplementation with one oral pill containing ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill
Related Therapeutic Areas
Sponsors
Leads: Southern Illinois University